Efficacy News and Research

RSS

Plant-based oil blend shows virucidal activity against SARS-CoV-2 and influenza viruses in vitro

A new preprint research paper posted to the bioRxiv* server offers a potential candidate for disinfecting the respiratory tract and mouth during and after exposure to the virus, in the form of proprietary herbal oil named Viruxal.

3 Jun 2021

Two repurposed drugs inhibit SARS-CoV-2 entry factors in a synergistic manner

A preprint paper uploaded to the bioRxiv* server shows how combining drugs targeting different entry factors of the host cell may prevent infection by the virus.

3 Jun 2021

Heterologous AstraZeneca and Pfizer vaccines induce strong immune response and T cell reactivity against multiple SARS-CoV-2 variants

Researchers from Germany recently analyzed a cohort of 26 individuals in the age range of 25 to 46 (median 30.5) years who had received a ChAdOx1 nCoV-19 prime vaccine followed by a BNT162b2 boost vaccine after a 56-day interval due to changing vaccine recommendations in Germany. There were 16 females and 10 males in the cohort, and they were assessed for immune responses, reactogenicity, and T cell reactivity. This study is published on the medRxiv* preprint server.

3 Jun 2021

Scientists identify many existing drugs with antiviral activity against coronavirus

Mining the world's most comprehensive drug repurposing collection for COVID-19 therapies, scientists have identified 90 existing drugs or drug candidates with antiviral activity against the coronavirus that's driving the ongoing global pandemic.

3 Jun 2021

Study: Some Type 2 diabetes patients can benefit from bone marrow stem cell transplants

Type 2 diabetes patients who are not overweight and who have had the disorder for less than a decade can benefit from stromal stem cells transplanted from their own bone marrow, according to a study published today in STEM CELLS Translational Medicine.

3 Jun 2021

How can nanomaterials help in the fight against COVID-19?

Researchers have reviewed different types of nanomaterials and how they can be used for the detection, prevention, and treatment of coronavirus disease 2019 (COVID-19).

3 Jun 2021

Researchers develop rapid antibody screening method for novel COVID-19 therapeutics development

New research undertaken by researchers in the USA describes two parallel but distinct in vivo approaches for the accelerated discovery of antibodies targeting SARS-CoV-2 spike protein.

3 Jun 2021

Known pharmaceutical compounds could provide new therapies for COVID-19

After screening over 12,000 existing treatments, researchers have found many promising antiviral compounds that could treat COVID-19.

3 Jun 2021

Study compares Pfizer and Moderna mRNA vaccine-elicited response to SARS-CoV-2 variants

A new study has been published on the bioRxiv preprint server which focuses on the correlation between the vaccine-triggered Immunoglobulin G (IgG) levels and neutralization titers against SARS-CoV-2 variants. Further, neutralization activities against the variants (B.1.1.7, B.1.525, and B.1.351), using Pfizer or Moderna vaccine, sera were assessed.

3 Jun 2021

Scientists assess the filtration efficacy of 227 models of face masks sold in Brazil

The novel coronavirus is transmitted mainly via inhalation of saliva droplets or respiratory secretions suspended in air, so that face covering and social distancing are the most effective ways to prevent COVID-19 until enough vaccines are available for all.

3 Jun 2021

New class of hydrogels can enable precise drug delivery

Hydrogels are commonly used inside the body to help in tissue regeneration and drug delivery. However, once inside, they can be challenging to control for optimal use. A team of researchers in the Department of Biomedical Engineering at Texas A&M University is developing a new way to manipulate the gel -- by using light.

3 Jun 2021

Centivax and US Naval Medical Research Center to begin Phase I clinical trial of antibody therapeutics

Centivax Inc. announced today that it has entered into a strategic partnership with the U.S. Naval Medical Research Center (NMRC) for Phase I clinical development of Centi-B9, Centivax's SARS-CoV-2 broad-spectrum injectable antibody therapeutic and prophylactic.

3 Jun 2021

New survey highlights key role of ECT for treating severe depression, other conditions

When the COVID-19 pandemic arrived in North America in March 2020, health care facilities stopped providing all but "essential" care, to reduce infection risks and preserve protective gear known as PPE.

3 Jun 2021

Study could help scientists, policymakers communicate about zoonotic diseases

A new study from North Carolina State University found that certain types of messages could influence how people perceive information about the spread of diseases from wildlife to humans.

3 Jun 2021

COVID-19 mortality in Israel and Europe after vaccination

The study, which appeared on the pre-print server, medRxiv*, confirms the potent efficacy of COVID-19 vaccination based on real-life public data in terms of protection against death.

2 Jun 2021

Gauging the efficacy and ease of use of at-home COVID-19 tests

As the country gets vaccinated and begins to re-open, testing remains a key element of safe interactions. Rapid testing for COVID-19 has become more common and accessible, including over-the-counter (OTC) tests approved by the U.S. Food and Drug Administration.

2 Jun 2021

New vaccine candidate with RBD and N protein targets protects against SARS-CoV-2 in preclinical trials

A recent study published in the journal Science Advances, explores the immunization of RBD with the P2 epitope of tetanus toxoid, to enhance its immunogenicity, and also tests the benefit of N protein in the vaccine.

2 Jun 2021

A newly developed electronic ‘nose’ could identify COVID-19-infection

Developing rapid diagnostic tools is key to dealing with the COVID-19 pandemic, and a new electronic-based ‘nose’ detector could identify cases in 80 seconds.

2 Jun 2021

“Cognitive clock” emerges as a new way to measure brain health

Researchers have developed a novel method to monitor the brain health of patients to improve the early diagnosis and treatment of certain diseases.

2 Jun 2021

SARS-CoV-2 can be neutralized by UV-A and UV-B

Since the end of the 1800s, Ultra-violet (UV) light has been widely documented for its germicidal properties. The UV-C light produced by low-pressure mercury tubes is widely used for disinfecting wastewater, closed environments, and biological products and is well-established, safe, and economical. UV light can have a germicidal effect on bacteria and viruses.

2 Jun 2021

Efficacy News and Research

Plant-based oil blend shows virucidal activity against SARS-CoV-2 and influenza viruses in vitro

Two repurposed drugs inhibit SARS-CoV-2 entry factors in a synergistic manner

Heterologous AstraZeneca and Pfizer vaccines induce strong immune response and T cell reactivity against multiple SARS-CoV-2 variants

Scientists identify many existing drugs with antiviral activity against coronavirus

Study: Some Type 2 diabetes patients can benefit from bone marrow stem cell transplants

How can nanomaterials help in the fight against COVID-19?

Researchers develop rapid antibody screening method for novel COVID-19 therapeutics development

Known pharmaceutical compounds could provide new therapies for COVID-19

Study compares Pfizer and Moderna mRNA vaccine-elicited response to SARS-CoV-2 variants

Scientists assess the filtration efficacy of 227 models of face masks sold in Brazil

New class of hydrogels can enable precise drug delivery

Centivax and US Naval Medical Research Center to begin Phase I clinical trial of antibody therapeutics

New survey highlights key role of ECT for treating severe depression, other conditions

Study could help scientists, policymakers communicate about zoonotic diseases

COVID-19 mortality in Israel and Europe after vaccination

Gauging the efficacy and ease of use of at-home COVID-19 tests

New vaccine candidate with RBD and N protein targets protects against SARS-CoV-2 in preclinical trials

A newly developed electronic ‘nose’ could identify COVID-19-infection

“Cognitive clock” emerges as a new way to measure brain health

SARS-CoV-2 can be neutralized by UV-A and UV-B

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News